Update
$Connect Biopharma(CNTB.US$ Connect Biopharma Announces Rademikibart Global Phase 2b Topline Results in Adult Patients With Moderate-to-Severe Persistent Asthma
announced today positive topline results from the global Phase 2b trial evaluating rademikibart efficacy and safety in adult patients with moderate-to-severe persistent asthma
Benzinga· 1 min ago![]()
Benzinga· 1 min ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Zahid007 : that's good news
TrytosaveabitOP Zahid007: Yes it is pretty great news! GL
Zahid007 : and look the share price now :-(
TrytosaveabitOP Zahid007: Yeah I see! But you can’t get a true idea of what the market will think until open! A lot of times you don’t know the true liquidity of a ticker during PM and AM? That’s what makes trading during them risky! GL
Zahid007 TrytosaveabitOP: one more news come. so it seems it will explode soon
TrytosaveabitOP Zahid007: Hoping!